Is MetLife Stock Fairly Priced?
MetLife’s stock (NYSE: MET) has made negligible gains YTD as compared to the 6% increase in the S&P500 index over the same period. Further, at its current price of $73 per share, it is trading 13% below its fair value of $84 – Trefis’ estimate for MetLife’s valuation. The insurance giant posted lower-than-expected results in the fourth quarter of 2022. It reported total revenues of $16.3 billion – down 19% y-o-y. The top line mainly suffered due to a 15% drop in the net investment income (NII), followed by a 29% decline in total premiums. That said, the adjusted net income grew 12% y-o-y to $1.3 billion due to a favorable drop in the policyholder benefits and claims as a % of revenues in Q4.
The company’s total adjusted revenues increased 8% y-o-y to $75.5 billion in FY 2022. Notably, total GAAP revenues were down 2% y-o-y to $69.9 billion. The growth was mainly due to higher total premiums – which increased 18% y-o-y to $49.4 billion, partially offset by a 26% decrease in the net investment income. In terms of operating segments, U.S. segment revenues rose by 24% y-o-y coupled with a 20% growth in the Latin America division. However, all the other units posted negative growth. On the flip side, the adjusted net income was reduced by 63% y-o-y to $2.35 billion in the year, primarily because of a significant jump in the total expenses figure.
Moving forward, we expect the net investment income to see some improvement over the subsequent quarters. Overall, MetLife revenues are forecast to remain around $69.8 billion in FY2023. Additionally, MET’s adjusted net income margin is likely to increase from the 2022 levels, resulting in an adjusted net income of $6.17 billion and an annual GAAP EPS of $8.21. This coupled with a P/E multiple of just above 10x will lead to a valuation of $84.
What if you’re looking for a more balanced portfolio instead? Our high-quality portfolio and multi-strategy portfolio have beaten the market consistently since the end of 2016.
| Returns | Feb 2023 MTD [1] |
2023 YTD [1] |
2017-23 Total [2] |
| MET Return | -1% | 0% | 47% |
| S&P 500 Return | 0% | 6% | 82% |
| Trefis Multi-Strategy Portfolio | 0% | 11% | 250% |
- MetLife Stock Is Trailing S&P500 In YTD Returns, What To Expect?
- Dropping 5% Since The Start Of 2023, Can MetLife Stock Rebound?
- Trailing The S&P Index By 30% YTD, Can MetLife Stock Recoup Its Losses?
- Where Is MetLife Stock Headed?
- MetLife Stock Has A 44% Upside To Its Pre-Inflation Peak
- What To Expect From MetLife Stock?
[1] Month-to-date and year-to-date as of 2/20/2023
[2] Cumulative total returns since the end of 2016
Invest with Trefis Market Beating Portfolios
See all Trefis Price Estimates